Metz-Boutigue MH - Search Results

1

Chromogranins: from discovery to current times.

Helle KB, Metz-Boutigue MH, Cerra MC, Angelone T. Helle KB, et al. Pflugers Arch. 2018 Jan;470(1):143-154. doi: 10.1007/s00424-017-2027-6. Epub 2017 Sep 5. Pflugers Arch. 2018. PMID: 28875377 Review.

2

Cateslytin abrogates lipopolysaccharide-induced cardiomyocyte injury by reducing inflammation and oxidative stress through toll like receptor 4 interaction.

Rocca C, De Bartolo A, Grande F, Rizzuti B, Pasqua T, Giordano F, Granieri MC, Occhiuzzi MA, Garofalo A, Amodio N, Cerra MC, Schneider F, Panno ML, Metz-Boutigue MH, Angelone T. Rocca C, et al. Among authors: metz boutigue mh. Int Immunopharmacol. 2021 May;94:107487. doi: 10.1016/j.intimp.2021.107487. Epub 2021 Feb 23. Int Immunopharmacol. 2021. PMID: 33636560

3

Peptides from the N-terminal domain of chromogranin A (vasostatins) exert negative inotropic effects in the isolated frog heart.

Tota B, Mazza R, Angelone T, Nullans G, Metz-Boutigue MH, Aunis D, Helle KB. Tota B, et al. Regul Pept. 2003 Jul 15;114(2-3):123-30. doi: 10.1016/s0167-0115(03)00112-5. Regul Pept. 2003. PMID: 12832100

4

Chromogranin A-derived peptides: interaction with the rat posterior cerebral artery.

Mandalà M, Brekke JF, Serck-Hanssen G, Metz-Boutigue MH, Helle KB. Mandalà M, et al. Regul Pept. 2005 Jan 15;124(1-3):73-80. doi: 10.1016/j.regpep.2004.07.002. Regul Pept. 2005. PMID: 15544843

5

Interactions of chromogranin A-derived vasostatins and monolayers of phosphatidylserine, phosphatidylcholine and phosphatidylethanolamine.

Blois A, Holmsen H, Martino G, Corti A, Metz-Boutigue MH, Helle KB. Blois A, et al. Regul Pept. 2006 Mar 15;134(1):30-7. doi: 10.1016/j.regpep.2005.11.003. Epub 2006 Jan 30. Regul Pept. 2006. PMID: 16445995

6

Full-length human chromogranin-A cardioactivity: myocardial, coronary, and stimulus-induced processing evidence in normotensive and hypertensive male rat hearts.

Pasqua T, Corti A, Gentile S, Pochini L, Bianco M, Metz-Boutigue MH, Cerra MC, Tota B, Angelone T. Pasqua T, et al. Endocrinology. 2013 Sep;154(9):3353-65. doi: 10.1210/en.2012-2210. Epub 2013 Jun 10. Endocrinology. 2013. PMID: 23751870

7

Chromofungin, CgA47-66-derived peptide, produces basal cardiac effects and postconditioning cardioprotective action during ischemia/reperfusion injury.

Filice E, Pasqua T, Quintieri AM, Cantafio P, Scavello F, Amodio N, Cerra MC, Marban C, Schneider F, Metz-Boutigue MH, Angelone T. Filice E, et al. Peptides. 2015 Sep;71:40-8. doi: 10.1016/j.peptides.2015.06.013. Epub 2015 Jul 4. Peptides. 2015. PMID: 26151429

8

The endocrine role for chromogranin A: a prohormone for peptides with regulatory properties.

Helle KB, Corti A, Metz-Boutigue MH, Tota B. Helle KB, et al. Cell Mol Life Sci. 2007 Nov;64(22):2863-86. doi: 10.1007/s00018-007-7254-0. Cell Mol Life Sci. 2007. PMID: 17717629 Review.

9

The homologous rat chromogranin A1-64 (rCGA1-64) modulates myocardial and coronary function in rat heart to counteract adrenergic stimulation indirectly via endothelium-derived nitric oxide.

Cerra MC, Gallo MP, Angelone T, Quintieri AM, Pulerà E, Filice E, Guérold B, Shooshtarizadeh P, Levi R, Ramella R, Brero A, Boero O, Metz-Boutigue MH, Tota B, Alloatti G. Cerra MC, et al. FASEB J. 2008 Nov;22(11):3992-4004. doi: 10.1096/fj.08-110239. Epub 2008 Aug 12. FASEB J. 2008. PMID: 18697842

10

The emerging cardioinhibitory role of the hippocampal cholinergic neurostimulating peptide.

Angelone T, Goumon Y, Cerra MC, Metz-Boutigue MH, Aunis D, Tota B. Angelone T, et al. J Pharmacol Exp Ther. 2006 Jul;318(1):336-44. doi: 10.1124/jpet.106.102103. Epub 2006 Apr 11. J Pharmacol Exp Ther. 2006. PMID: 16608915

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

122 results

Search Page